Oncocenter Oncologie Clinica S.R.L.
- Address
- lock Available on a paid plan
Neoplasms (Cancer)
The Oncocenter Oncologie Clinica S.R.L. in Timisoara conducts a portfolio of studies targeting a range of solid tumors, with a focus on advancing therapeutic options for patients with advanced or early‑stage disease.
- Advanced or recurrent endometrial cancer
- Breast neoplasms, including ER+/HER2‑ negative early breast cancer
- Melanoma, both unresectable/metastatic and post‑surgical settings
- Resectable stage II‑IIIA‑B non‑small cell lung cancer
- c‑Met overexpressing EGFR wild‑type non‑squamous NSCLC
- Immunotherapy‑naïve solid tumors
Across ten active trials, investigators are evaluating novel agents, combination regimens, and extended endocrine therapies to improve progression‑free survival, overall survival, and relapse‑free outcomes. The site’s multidisciplinary team collaborates to bring cutting‑edge treatments to patients while gathering safety and efficacy data for future approvals.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 47 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 45 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
- 1Regeneron Pharmaceuticals Inc.2active
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Regeneron Pharmaceuticals Inc.5trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oncocenter Oncologie Clinica S.R.L.
lock Showing 1 of 33 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE | Incyte Corp. | Phase II | Not Recruiting | Nov 2023 | Feb 2026 |
IMP list
lock Showing 1 of 47 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 10 | Unknown | 2018-03-21 | 2026-01-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.